MTOR and leukemia: Key phosphoproteins in AMPK/PI3K/mTOR signaling were stimulated by stroma-dependent protection with HDACi treatment of leukemia for which its protein network kinase activities have been previously shown to protect leukemia cells by suppressing oxidative stress in the bone marrow microenvironment [41].